Buscar
Mostrando ítems 1-10 de 571
Acute myocardial infarction mortality in Chile. Thrombolysis or angioplasty Mortalidad por infarto del miocardio en Chile. Trombolíticos o angioplastía
(2011)
During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and ...
Infarct Size as Predictor of Systolic Functional Recovery after Myocardial Infarction
(Arquivos Brasileiros Cardiologia, 2014-06-01)
Background: The effects of modern therapy on functional recovery after acute myocardial infarction (AMI) are unknown.Objectives: To evaluate the predictors of systolic functional recovery after anterior AMI in patients ...
Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital
(Sociedade Brasileira de Cardiologia (SBC), 2002-04-01)
OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We ...
Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital
(Sociedade Brasileira de Cardiologia (SBC), 2002-04-01)
OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We ...
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
(Elsevier, 2022)
Background: Morphine is commonly used to relieve pain, anxiety and dyspnea in STEMI but it lowers blood pressure and delays the activity of oral antiplatelet agents. The impact of morphine on clinical outcomes remains ...
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: Evolution toward prospective theranostic approaches
(Ivyspring International Publisher, 2018)
© Ivyspring International Publisher. Cardiovascular diseases are the leading cause of death worldwide. Despite preventive efforts, early detection of atherosclerosis, the common pathophysiological mechanism underlying ...
Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
(Mdpi, 2020-05-01)
Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally, representing approximately a third of all deaths every year. The greater part of these cases is represented by myocardial infarction ...
Angioplastia primaria en el infarto agudo de miocardio
(Sociedad Uruguaya de Cardiología, 2013)
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Objectives Predictors of adverse outcomes following myocardial infarction (MI) are well established; however, little is known about what predicts enzymatically estimated infarct size in patients with acute ST-elevation MI. ...
Clinical features and prognosis of acute myocardial infarction among patients aged 80 years or older Infarto agudo al miocardio en pacientes de 80 y más años. Evolución hospitalaria y seguimiento
(2008)
Background: Subjects older than 80 years have more complicated acute myocardial infarctions and are subjected to less reperfusion procedures. Aim: To describe the hospital evolution and follow up of patients older than 80 ...